No Data
No Data
Press Release: FibroBiologics Announces 2024 Annual Meeting of Stockholders
FibroBiologics Announces 2024 Annual Meeting of Stockholders HOUSTON, May 15, 2024 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) ("FibroBiologics"), a clinical-stage biotechnology company w
FibroBiologics 1Q Loss/Shr 27c >FBLG
FibroBiologics 1Q Loss/Shr 27c >FBLG
FibroBiologics | 10-Q: Quarterly report
FibroBiologics to Present at the BIO International Convention 2024
HOUSTON, May 07, 2024 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (NASDAQ:FBLG) ("FibroBiologics"), a clinical-stage biotechnology company with 150+ patents issued and pending with a focus on the development of
FibroBiologics Files to Sell 1.8M Units
Express News | Fibrobiologics Files for Offering of up to 1.8 Mln Units, Each Consisting of One Common Share, One Warrant to Purchase One Common Share - SEC Filing
No Data